Loading…
To amend title XVIII of the Social Security Act to provide for the expansion of coverage of vaccines under part B of the Medicare program, and for other purposes.
Legislative Progress
Introduced
November 17, 2021
Latest Action
November 18, 2021
Primary Sponsor
Tom O’HalleranDemocratic(AZ)
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
43pct
1d open
vs 9,698 other HR bills in the 117th — cohort avg 63d
This bill expands Medicare coverage of vaccines to include any vaccine for adults that is recommended by the Advisory Committee on Immunization Practices of the Centers for Disease Control and Prevention. Currently, Medicare covers vaccines for influenza, hepatitis B, pneumococcal disease, and COVID-19.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (5)
H.R. 8018/S. 3109 Alleviating Barriers for Caregivers Act. No bill number. Discussed retirement issues. S. 4398, the Retirement Investment in Small Employers Act. H.R. 6007, the Retirement Investment in Small Employers Act. H.R. 6065, the Retirement Savings for Americans Act of 2023. S. 3102, Retirement Savings for Americans Act of 2023. H.R. 5060, Women's Retirement Protection Act. S. 2627, the Women's Retirement Protection Act. S. 2517/ H.R. 4924, the Auto Reenroll Act of 2023. H.R. 7293, the Automatic IRA Act of 2024. No bill number. Discussed Social Security cost-of-living adjustments. S. 597/H.R. 82, the Social Security Fairness Act of 2023. H.R. 5342, the Equal Treatment of Public Servants Act of 2023. H.R. 4260, the Public Servants Protection and Fairness Act of 2023. No bill number. Discussed customer service at the Social Security Administration. No bill number. Discussed Social Security solvency and financing. No bill number. Discussed fast track entitlement and fiscal commission. S. 2767/H.R. 5408, the SSI Savings Penalty Elimination Act. H.R. 4289 (117th Congress), WISH Act
Referred to the Subcommittee on Health.
Referred to the Subcommittee on Health.
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Introduced in House
Congress.gov source codes: 1000, Intro-H
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Client expense: $5,580,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Labor, Dept of (DOL), SENATE, Social Security Administration (SSA), Treasury, Dept of, White House Office
2023 · fourth_quarter · Retirement
SEC Open-End Fund Liquidity Risk Management Programs and Swing Pricing proposed rule; H.R. 5337 Retirement Proxy Protection Act H.R. 5338 No Discrimination in My Benefits Act H.R. 5339 RETIRE Act H.R. 5340 Providing Complete Information to Retirement Investors Act Amendments to H.R. 2670, the National Defense Authorization Act for Fiscal Year 2024 DOL Fiduciary Rule Qualified Professional Asset Manager PTE Changes; Public Law 117-328 - Consolidated Appropriations Law (Secure 2.0 retirement provisions) Retirement Security Rule: Definition of an Investment Advice Fiduciary (EBSA) and related exemptions. Independent Contractor Rule RIN 0985-AA18 NPRM - Adult Protective Services Functions and Grant Programs, Administration for Community Living, HHS To amend the Internal Revenue Code of 1986 and the Employee Retirement Income Security Act of 1974 to make technical corrections relating to the SECURE 2.0 Act of 2022, and for other purposes SECURE 2.0 Implementation RIN 1210-AC23 RFI - SECURE 2.0 Reporting and Disclosure, EBSA Basel III End Game and Retirement Employee Identification Number (EIN) / Unrelated Business Taxable Income (UBTI) IRS H.R. 6640 To amend the Internal Revenue Code of 1986 for purposes of the tax on private foundation excess business holdings to treat as outstanding any employee-owned stock purchased by a business enterprise pursuant to certain employee stock ownership retirement plans. Amendment No. 83 to H.R. 5894 - Labor, Health and Human Services, Education, and Related Agencies Appropriations Act, 2024 H.R. 6065/ S. 3102 Retirement Savings for Americans Act H.R. 6007, Retirement Investment in Small Employers Act H.R.5673, Responsible Legislating Act Section 4966 Donor Advised Fund Regulations H.R. 6065, To establish the American Worker Retirement Plan, improve the financial security of working Americans by facilitating the accumulation of wealth, and for other purposes.
Client expense: $2,990,000 · Firm income: Not reported
Government targets: Commodity Futures Trading Commission (CFTC), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Labor, Dept of (DOL), SENATE, Securities & Exchange Commission (SEC), Treasury, Dept of
2022 · fourth_quarter · Health Issues
- HR 1978/S 912, "Protecting Seniors Through Immunization Act", regarding all provisions - HR 6007, "To amend title XVIII of the Social Security Act to provide for the expansion of coverage of vaccines under part B of the Medicare program, and for other purposes", regarding all provisions - H.Res. 446, Expressing support for the goals and ideals of National Stroke Awareness Month, regarding all provisions - S 610/HR 1667, "The Dr. Lorna Breen Health Care Provider Protection Act", regarding all provisions - HR 3, "Elijah E. Cummings Lower Drug Costs Now Act", regarding all provisions - S 1784/HR 3353, Contact Lens Prescription Verification Modernization Act, regarding all provisions - HR 5030/S 2706, "The Diversifying Investigations Via Equitable Research Studies for Everyone (DIVERSE) Trials Act, regarding all provisions - S 3394, "Emergency Use Transparency Act", regarding all provisions - HR 3990/S 2047, "No PFAS in Cosmetics Act", regarding all provisions - HR 8299/S 4386, "To allow for devices with a predetermined change control plan to be marketed without submitting a supplemental application or premarket notification if the changes to such devices are consistent with such plan.", regarding all provisions - HR 7667/S 4348, "Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act", regarding provisions on accelerated approval and diversity in clinical studies - HR 5801, "HELP Copays Act", regarding all provisions - HR 3173/S 3018 - "Improving Seniors Timely Access to Care Act of 2021", regarding all provisions - S 3799 - "PREVENT Pandemics Act", regarding all provisions - HR 3932/S 2076 - "PASTEUR Act of 2021", regarding all provisions - HR 5376 - "Inflation Reduction Act", regarding provisions on drug pricing and provisions related to revenue - HR 7559 - Prescription Information Modernization Act of 2022, regarding all provisions - HR 2617 - "Consolidated Appropriations Act, 2023", regarding provisions related to pharmaceuticals, medical devices, mental health, and tax - Issues related to Dengue - Issues related to prescription drug pricing - Issues related to health care pricing transparency - Issues related to maternal health - Issues related to frontline health workers - Issues related to over the counter products - Issues related to the regulation of cosmetic products - Issues related to the regulation of dietary supplements - Issues related to stroke care - Issues related to counterfeit health care goods - Issues related to 340B drug pricing program - Issues related to antimicrobial resistance - Issues related to the COVID-19 vaccine development, including diversity in clinical trials - Issues related to Medicare Part D's 6 protected classes - Issues related to global public health and ending tuberculosis - Issues pertaining to health equity and social determinants of health - Issues related to FDA medical device shortage reporting requirements, including implementation of CARES Act requirements - Issues related to lung cancer screening - Issues related to clinical research diversity - Issues related to international harmonization of medical device regulation
Client expense: $2,270,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2022 · fourth_quarter · Medicare/Medicaid
H.R. 6007, Expansion of Coverage of Vaccines under Part B of the Medicare Program. Monitored implementation of H.R. 5376 (P.L. 117-169), the Inflation Reduction Act, as it relates to drug pricing issues. Monitored S. 3700 / H.R. 6833, Affordable Insulin Now Act. Monitored issues related to H.R. 3173, the Improving Seniors' Timely Access to Care Act. H.R. 2617 (P.L. 117-328), the Consolidated Appropriations Act of 2023, as it relates to Medicare physician payment and mental health.
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · fourth_quarter · Health Issues
H.R. 2617, Consolidated Appropriations Act, 2023 - allowing new vaccines to be added to the Vaccine Injury Compensation Fund (VICF); Issues related to reauthorization of FDA user fee bills (H.R. 7667, Food and Drug Amendments of 2022; S. 4348, Food and Drug Administration Safety and Landmark Advancements Act of 2022 (FDSLA Act of 2022)), including accelerated approval and reimportation; Issues related to the Public Health Emergency; Issues related to COVID-19 vaccines, manufacturing, and distribution; H.R. 7007, COVID Supplemental Appropriations Act, 2022; Consolidated Appropriations Act, 2022 (PL 117-103); S. 3799, PREVENT Pandemics Act; H.R. 6007, To amend title XVIII of the Social Security Act to provide for the expansion of coverage of vaccines under part B of the Medicare program, and for other purposes; Issues related to Vaccine Injury Compensation Fund (VICF); Executive Order Directing HHS to Explore Additional Actions to Lower Prescription Drug Costs
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · third_quarter · Medicare/Medicaid
H.R. 6007, Expansion of Coverage of Vaccines under Part B of the Medicare Program. Drug pricing issues related to H.R. 5376 (P.L. 117-169), the Inflation Reduction Act. Issues concerning mental health. Monitored S. 3700 / H.R. 6833, Affordable Insulin Now Act. Monitored issues related to H.R. 3173, the Improving Seniors' Timely Access to Care Act.
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · third_quarter · Health Issues
- HR 1978/S 912, "Protecting Seniors Through Immunization Act", regarding all provisions - HR 6007, "To amend title XVIII of the Social Security Act to provide for the expansion of coverage of vaccines under part B of the Medicare program, and for other purposes", regarding all provisions - H.Res. 446, Expressing support for the goals and ideals of National Stroke Awareness Month, regarding all provisions - S 610/HR 1667, "The Dr. Lorna Breen Health Care Provider Protection Act", regarding all provisions - HR 3, "Elijah E. Cummings Lower Drug Costs Now Act", regarding all provisions - S 1784/HR 3353, Contact Lens Prescription Verification Modernization Act, regarding all provisions - HR 5030/S 2706, "The Diversifying Investigations Via Equitable Research Studies for Everyone (DIVERSE) Trials Act, regarding all provisions - S 3394, "Emergency Use Transparency Act", regarding all provisions - HR 5376, "Build Back Better Act", regarding provisions on drug pricing and provisions related to revenue - HR 3990/S 2047, "No PFAS in Cosmetics Act", regarding all provisions - HR 8299/S 4386, FDA review of certain changes to software in medical devices or predetermined change control plans - HR 7667/S 4348, "Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act", regarding provisions on accelerated approval and diversity in clinical studies - HR 5801, "HELP Copays Act", regarding all provisions - HR 3173/S 3018 - "Improving Seniors Timely Access to Care Act of 2021" - S 3799 - "PREVENT Pandemics Preparedness Act" - HR 3932/S 2079 - "PASTEUR Act of 2021" - HR 5376 - "Inflation Reduction Act", regarding provisions on prescription drugs - Issues related to Dengue - Issues related to prescription drug pricing - Issues related to health care pricing transparency - Issues related to maternal health - Issues related to frontline health workers - Issues related to over the counter products - Issues related to the regulation of cosmetic products - Issues related to the regulation of dietary supplements - Issues related to stroke care - Issues related to counterfeit health care goods - Issues related to 340B drug pricing program - Issues related to antimicrobial resistance - Issues related to the COVID-19 vaccine development, including diversity in clinical trials - Issues related to Medicare Part D's 6 protected classes - Issues related to global public health and ending tuberculosis - Issues pertaining to health equity and social determinants of health - Issues related to FDA medical device shortage reporting requirements, including implementation of CARES Act requirements - Issues related to lung cancer screening - Issues related to clinical research diversity - Issues related to international harmonization of medical device regulation
2022 · third_quarter · Health Issues
Issues related to the implementation of the Inflation Reduction Act of 2022, PL 117-169; Issues related to the Continuing Resolution, H.R.6833; Issues related to reauthorization of FDA user fee bills (H.R. 7667, Food and Drug Amendments of 2022; S. 4348, Food and Drug Administration Safety and Landmark Advancements Act of 2022 (FDSLA Act of 2022)), including accelerated approval and reimportation; Issues related to the Public Health Emergency; Issues related to COVID-19 vaccines, manufacturing, and distribution; H.R. 7007, COVID Supplemental Appropriations Act, 2022; Consolidated Appropriations Act, 2022 (PL 117-103); S. 3799, PREVENT Pandemics Act; H.R. 5585, The Advanced Research Project Agency-Health (ARPA-H) Act; Issues related to the FY 2023 President's Budget; H.R. 6007, To amend title XVIII of the Social Security Act to provide for the expansion of coverage of vaccines under part B of the Medicare program, and for other purposes
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · second_quarter · Health Issues
- HR 1978/S 912, "Protecting Seniors Through Immunization Act", regarding all provisions - HR 6007, "To amend title XVIII of the Social Security Act to provide for the expansion of coverage of vaccines under part B of the Medicare program, and for other purposes", regarding all provisions - H.Res. 446, Expressing support for the goals and ideals of National Stroke Awareness Month, regarding all provisions - S 610/HR 1667, "The Dr. Lorna Breen Health Care Provider Protection Act", regarding all provisions - HR 3, "Elijah E. Cummings Lower Drug Costs Now Act", regarding all provisions - S 1784/HR 3353, Contact Lens Prescription Verification Modernization Act, regarding all provisions - HR 5030/S 2706, "The Diversifying Investigations Via Equitable Research Studies for Everyone (DIVERSE) Trials Act, regarding all provisions - S 3394, "Emergency Use Transparency Act", regarding all provisions - HR 5376, "Build Back Better Act", regarding provisions on drug pricing and provisions related to revenue - HR 3990/S 2047, "No PFAS in Cosmetics Act", regarding all provisions - HR 8299/S 4386, FDA review of certain changes to software in medical devices or predetermined change control plans - HR 7667/S 4348, "Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act", regarding provisions on accelerated approval and diversity in clinical studies - HR 5801, "HELP Copays Act", regarding all provisions - Issues related to prescription drug pricing - Issues related to health care pricing transparency - Issues related to maternal health - Issues related to frontline health workers - Issues related to over the counter products - Issues related to the regulation of cosmetic products - Issues related to the regulation of dietary supplements - Issues related to stroke care - Issues related to counterfeit health care goods - Issues related to 340B drug pricing program - Issues related to antimicrobial resistance - Issues related to the COVID-19 vaccine development, including diversity in clinical trials - Issues related to Medicare Part D's 6 protected classes - Issues related to global public health and ending tuberculosis - Issues pertaining to health equity and social determinants of health - Issues related to FDA medical device shortage reporting requirements, including implementation of CARES Act requirements - Issues related to lung cancer screening - Issues related to clinical research diversity - Issues related to international harmonization of medical device regulation
2022 · second_quarter · Health Issues
Issues related to COVID-19 vaccines, manufacturing, and distribution; H.R. 7007, COVID Supplemental Appropriations Act, 2022; Consolidated Appropriations Act, 2022 (PL 117-103); S. 3799, PREVENT Pandemics Act; H.R. 5585, The Advanced Research Project Agency-Health (ARPA-H) Act; Issues related to the FY 2023 Presidents Budget; HR 6007, To amend title XVIII of the Social Security Act to provide for the expansion of coverage of vaccines under part B of the Medicare program, and for other purposes
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · second_quarter · Medicare/Medicaid
H.R. 6007, Expansion of Coverage of Vaccines under Part B of the Medicare Program. Issues related to maternal health. Issues related to COVID relief. Monitored drug pricing issues related to H.R. 5376, The Build Back Better Act. Issues concerning mental health. Monitored S. 3700 / H.R. 6833, Affordable Insulin Now Act.
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · second_quarter · Government Issues
Issues regarding COVID relief. Issues related to mental health. Issues related to FDA user fee agreements. H.R. 6007, Expansion of Coverage of Vaccines under Part B of the Medicare Program. Issues related to maternal health. Monitored drug pricing issues related to H.R. 5376, The Build Back Better Act. Monitored H.R. 6833, Affordable Insulin Now Act. Issues related to diversity in clinical trials, including H.R. 5030, DIVERSE Trials Act. Monitored issues related to H.R. 3173, Improving Seniors Timely Access to Care Act.
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES
2022 · first_quarter · Health Issues
- HR 1978/S 912, "Protecting Seniors Through Immunization Act", regarding all provisions - HR 6007, legislation to expand access to adult vaccines under Medicare Part B, regarding all provisions - H.Res. 446, Expressing support for the goals and ideals of National Stroke Awareness Month - S 610/HR 1667, "The Dr. Lorna Breen Health Care Provider Protection Act" - HR 3, "Elijah E. Cummings Lower Drug Costs Now Act", regarding all provisions - S 1784/HR 3353, the Contact Lens Prescription Verification Modernization Act, regarding all provisions - HR 5030/S 2706, "The Diversifying Investigations Via Equitable Research Studies for Everyone (DIVERSE) Trials Act, regarding all provisions - S 3394, "The Emergency Use Transparency Act", regarding all provisions - HR 5376, "Build Back Better Act", regarding provisions on drug pricing and provisions related to revenue - HR 3990/S 2047, No PFAS in Cosmetics Act - HR 2467, PFAS Action Act of 2021 - Issues related to prescription drug pricing - Issues related to health care pricing transparency - Issues related to maternal health - Issues related to frontline health workers - Issues related to over the counter products - Issues related to the regulation of cosmetic products - Issues related to the regulation of dietary supplements - Issues related to stroke care - Issues related to counterfeit health care goods - Issues related to 340B drug pricing program - Issues related to antimicrobial resistance - Issues related to the COVID-19 vaccine development, including diversity in clinical trials - Issues related to Medicare Part D's 6 protected classes - Issues related to global public health and ending tuberculosis - Issues pertaining to health equity and social determinants of health - Issues related to FDA medical device shortage reporting requirements, including implementation of CARES Act requirements - Issues related to lung cancer screening - Issues related to clinical research diversity - Issues related to international harmonization of medical device regulation - Issues related to FDA review of certain changes to software in medical devices or predetermined change control plans - Issues related to HR ___, "Medical Device User Fee Amendments of 2022"
2022 · first_quarter · Medicare/Medicaid
H.R. 6007, Expansion of Coverage of Vaccines under Part B of the Medicare Program. Issues related to maternal health. Issues related to COVID relief. Monitored drug pricing issues related to H.R. 5376, The Build Back Better Act. Issues concerning mental health. Monitored S. 3700 / H.R. 6833, Affordable Insulin Now Act.
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · first_quarter · Government Issues
Monitored implementation of P.L. 117-2, the American Rescue Plan, as it relates to COVID relief. Issues regarding COVID relief. Issues related to mental health. Issues related to FDA user fee agreements. H.R. 6007, Expansion of Coverage of Vaccines under Part B of the Medicare Program. Issues related to maternal health. Monitored drug pricing issues related to H.R. 5376, The Build Back Better Act. Monitored H.R. 6833, Affordable Insulin Now Act. Issues related to diversity in clinical trials, including H.R. 5030, DIVERSE Trials Act.
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES
2021 · fourth_quarter · Medicare/Medicaid
H.R. 6007, Expansion of Coverage of Vaccines under Part B of the Medicare Program. Monitored implementation of P.L. 117-2, the American Rescue Plan, as it relates to COVID relief. Issues related to maternal health. Monitored drug pricing issues related to H.R. 3, the Elijah E. Cummings Lower Drug Costs Now Act, H.R. 5376, The Build Back Better Act, and H.R. 19/S. 2164, the Lower Costs, More Cures Act. Monitored H.R. 3684 (P.L. 117-58), The Infrastructure Investment and Jobs Act, as it relates to drug pricing.
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Client expense: $2,170,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Client expense: $1,050,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Client expense: $2,320,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE